What is "women-focused" treatment for substance use disorders? - PubMed (original) (raw)

What is "women-focused" treatment for substance use disorders?

Shelly F Greenfield et al. Psychiatr Serv. 2009 Jul.

Abstract

Over the past three decades research has highlighted gender differences in substance use disorders and substance abuse treatment participation. Programs devoted to addressing women's treatment needs, broadly encompassed in the term "women-focused treatment," have multiplied. This column examines the rationale for women-focused treatment and describes some of its components. The authors cite the need to evaluate women-focused treatment by developing validated measures of the processes embodied in such treatment and by conducting empirically sound research on clinical outcomes, treatment effectiveness, cost-effectiveness, and the optimal means of providing services to women with substance use disorders.

PubMed Disclaimer

Similar articles

• Women and children last. Barriers to drug treatment for women.
  Brown L. Brown L. Health PAC Bull. 1992 Summer;22(2):15-9. Health PAC Bull. 1992. PMID: 10171224 No abstract available.
• Women, Co-occurring Disorders, and Violence Study: evaluation design and study population.
  McHugo GJ, Kammerer N, Jackson EW, Markoff LS, Gatz M, Larson MJ, Mazelis R, Hennigan K. McHugo GJ, et al. J Subst Abuse Treat. 2005 Mar;28(2):91-107. doi: 10.1016/j.jsat.2004.08.009. J Subst Abuse Treat. 2005. PMID: 15780539
• Low-income women's use of substance abuse and mental health services.
  Rosen D, Tolman RM, Warner LA. Rosen D, et al. J Health Care Poor Underserved. 2004 May;15(2):206-19. doi: 10.1353/hpu.2004.0028. J Health Care Poor Underserved. 2004. PMID: 15253374
• They should have listened.
  Barron J. Barron J. Ment Health Today. 2004 Oct:29-31. Ment Health Today. 2004. PMID: 15553972 Review. No abstract available.
• Gender and equity in health sector reform programmes: a review.
  Standing H. Standing H. Health Policy Plan. 1997 Mar;12(1):1-18. doi: 10.1093/heapol/12.1.1. Health Policy Plan. 1997. PMID: 10166098 Review.

Cited by

• Sex Differences in Opioid Use Disorder Prevalence and Multimorbidity Nationally in the Veterans Health Administration.
  Peltier MR, Sofuoglu M, Petrakis IL, Stefanovics E, Rosenheck RA. Peltier MR, et al. J Dual Diagn. 2021 Apr-Jun;17(2):124-134. doi: 10.1080/15504263.2021.1904162. Epub 2021 May 13. J Dual Diagn. 2021. PMID: 33982642 Free PMC article.
• "If you're strung out and female, they will take advantage of you": A qualitative study exploring drug use and substance use service experiences among women in Boston and San Francisco.
  Harris MTH, Laks J, Hurstak E, Jain JP, Lambert AM, Maschke AD, Bagley SM, Farley J, Coffin PO, McMahan VM, Barrett C, Walley AY, Gunn CM. Harris MTH, et al. J Subst Use Addict Treat. 2024 Feb;157:209190. doi: 10.1016/j.josat.2023.209190. Epub 2023 Oct 20. J Subst Use Addict Treat. 2024. PMID: 37866442 Free PMC article.
• A Preliminary Study Examining Women's Physical Health and Nonmedical Prescription Opioid Use in a Recovering Framework.
  Marks KR, Leukefeld CG. Marks KR, et al. J Womens Health (Larchmt). 2017 Mar;26(3):286-293. doi: 10.1089/jwh.2016.5961. Epub 2017 Jan 10. J Womens Health (Larchmt). 2017. PMID: 28072916 Free PMC article.
• Predictors of Post-Treatment Employment for Individuals with Substance Use Disorders.
  Kim M, Leierer S, Jeon J. Kim M, et al. Community Ment Health J. 2019 Oct;55(7):1236-1245. doi: 10.1007/s10597-019-00439-z. Epub 2019 Jul 2. Community Ment Health J. 2019. PMID: 31267298
• Patterns of Socioeconomic Marginalization among People Who Use Drugs: A Gender-Stratified Repeated Measures Latent Class Analysis.
  Mitra S, Kerr T, Cui Z, Gilbert M, Fleury M, Hayashi K, Milloy MJ, Richardson L. Mitra S, et al. J Urban Health. 2024 Apr;101(2):402-425. doi: 10.1007/s11524-024-00828-0. Epub 2024 Mar 12. J Urban Health. 2024. PMID: 38472731

References

1. 1. Grella CE. From generic to gender-responsive treatment: changes in social policies, treatment services, and outcomes of women in substance abuse treatment. Journal of Psychoactive Drugs. 2008;5(suppl):327–343. - PubMed
2. 1. NIH Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research. National Institutes of Health; Bethesda, Md: 1994. (NIH guide 23).
3. 1. Treatment Methods for Women. National Institute on Drug Abuse; Bethesda, Md: 1999. Available at www.nida.nih.gov/info facts/treatwomen.html.
4. 1. Greenfield SF, Brooks AJ, Gordon SM, et al. Substance abuse treatment entry, retention, and outcome in women: a review of the literature. Drug and Alcohol Dependence. 2007;86(1):1–21. - PMC - PubMed
5. 1. Greenfield SF, Trucco EM, McHugh RK, et al. The Women's Recovery Group Study: a stage I trial of women-focused group therapy for substance use disorders versus mixed-gender group drug counseling. Drug and Alcohol Dependence. 2007;90(1):39–47. - PMC - PubMed

Publication types

MeSH terms

Grants and funding

• R01-DA015434/DA/NIDA NIH HHS/United States
• R01 DA015390/DA/NIDA NIH HHS/United States
• K24 DA019855/DA/NIDA NIH HHS/United States
• R01-DA015390/DA/NIDA NIH HHS/United States
• K24-DA019855/DA/NIDA NIH HHS/United States
• R01 DA015434/DA/NIDA NIH HHS/United States
• R01 DA015390-04/DA/NIDA NIH HHS/United States

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central

• Medical

  • MedlinePlus Consumer Health Information
  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal